Eli Lilly and Company (NYSE:LLY) Stock Rating Lowered by Hsbc Global Res
Eli Lilly and Company (NYSE:LLY – Get Free Report) was downgraded by analysts at Hsbc Global Res from a “strong-buy” rating to a “moderate sell” rating in a note issued to investors on Monday,Zacks.com reports. LLY has been the subject of several other research reports. Leerink Partners set a $950.00 target price on Eli Lilly […]
